Literature DB >> 22510873

An activating intragenic deletion in NOTCH1 in human T-ALL.

J Erika Haydu1, Kim De Keersmaecker, Mary Kaye Duff, Elisabeth Paietta, Janis Racevskis, Peter H Wiernik, Jacob M Rowe, Adolfo Ferrando.   

Abstract

Oncogenic activating mutations in NOTCH1 occur in more than 50% of T-cell acute lymphoblastic leukemias (T-ALLs). In the present study, we describe a novel mechanism of NOTCH1 activation in T-ALL in which a deletion removing the 5' portion of NOTCH1 abolishes the negative regulatory control of the extracellular domain and leads to constitutively active NOTCH1 signaling. Polypeptides translated from truncated transcripts encoded by the NOTCH1 deletion allele retain the transmembrane domain of the receptor and are constitutively cleaved by the γ-secretase complex, resulting in high levels of NOTCH1 signaling that can be effectively blocked by γ-secretase inhibitors. Our results expand the spectrum of oncogenic lesions activating NOTCH1 signaling in human T-ALL.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22510873      PMCID: PMC3369611          DOI: 10.1182/blood-2011-10-388504

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

2.  NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL.

Authors:  Maria Luisa Sulis; Odette Williams; Teresa Palomero; Valeria Tosello; Sasikala Pallikuppam; Pedro J Real; Kelly Barnes; Linda Zuurbier; Jules P Meijerink; Adolfo A Ferrando
Journal:  Blood       Date:  2008-04-14       Impact factor: 22.113

3.  Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes.

Authors:  Michael J Malecki; Cheryll Sanchez-Irizarry; Jennifer L Mitchell; Gavin Histen; Mina L Xu; Jon C Aster; Stephen C Blacklow
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

4.  CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors.

Authors:  T Palomero; K C Barnes; P J Real; J L Glade Bender; M L Sulis; V V Murty; A I Colovai; M Balbin; A A Ferrando
Journal:  Leukemia       Date:  2006-05-11       Impact factor: 11.528

5.  Deficient T cell fate specification in mice with an induced inactivation of Notch1.

Authors:  F Radtke; A Wilson; G Stark; M Bauer; J van Meerwijk; H R MacDonald; M Aguet
Journal:  Immunity       Date:  1999-05       Impact factor: 31.745

Review 6.  Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies.

Authors:  Jon C Aster; Stephen C Blacklow; Warren S Pear
Journal:  J Pathol       Date:  2010-10-21       Impact factor: 7.996

Review 7.  Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia.

Authors:  A A Ferrando; A T Look
Journal:  Semin Hematol       Date:  2000-10       Impact factor: 3.851

Review 8.  The role of NOTCH1 signaling in T-ALL.

Authors:  Adolfo A Ferrando
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

Review 9.  Gene expression profiling in T-cell acute lymphoblastic leukemia.

Authors:  Adolfo A Ferrando; A Thomas Look
Journal:  Semin Hematol       Date:  2003-10       Impact factor: 3.851

Review 10.  Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think.

Authors:  Camille Lobry; Philmo Oh; Iannis Aifantis
Journal:  J Exp Med       Date:  2011-09-26       Impact factor: 14.307

View more
  12 in total

1.  The NOTCH signaling pathway: role in the pathogenesis of T-cell acute lymphoblastic leukemia and implication for therapy.

Authors:  Valeria Tosello; Adolfo A Ferrando
Journal:  Ther Adv Hematol       Date:  2013-06

2.  Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia.

Authors:  Giulia Fabbri; Antony B Holmes; Mara Viganotti; Claudio Scuoppo; Laura Belver; Daniel Herranz; Xiao-Jie Yan; Yasmine Kieso; Davide Rossi; Gianluca Gaidano; Nicholas Chiorazzi; Adolfo A Ferrando; Riccardo Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-17       Impact factor: 11.205

Review 3.  V(D)J Recombination: Mechanism, Errors, and Fidelity.

Authors:  David B Roth
Journal:  Microbiol Spectr       Date:  2014-12

4.  Inhibition of γ-secretase activity synergistically enhances tumour necrosis factor-related apoptosis-inducing ligand induced apoptosis in T-cell acute lymphoblastic leukemia cells via upregulation of death receptor 5.

Authors:  Lisa M Greene; Seema M Nathwani; Daniela M Zisterer
Journal:  Oncol Lett       Date:  2016-08-16       Impact factor: 2.967

5.  Genetic Analysis of T Cell Lymphomas in Carbon Ion-Irradiated Mice Reveals Frequent Interstitial Chromosome Deletions: Implications for Second Cancer Induction in Normal Tissues during Carbon Ion Radiotherapy.

Authors:  Benjamin J Blyth; Shizuko Kakinuma; Masaaki Sunaoshi; Yoshiko Amasaki; Shinobu Hirano-Sakairi; Kanae Ogawa; Ayana Shirakami; Yi Shang; Chizuru Tsuruoka; Mayumi Nishimura; Yoshiya Shimada
Journal:  PLoS One       Date:  2015-06-30       Impact factor: 3.240

6.  The emerging roles of Notch signaling in leukemia and stem cells.

Authors:  Na Liu; Jingru Zhang; Chunyan Ji
Journal:  Biomark Res       Date:  2013-07-18

7.  Overexpression of CD59 inhibits apoptosis of T-acute lymphoblastic leukemia via AKT/Notch1 signaling pathway.

Authors:  Yanfei Jia; Yan Qi; Yunshan Wang; Xiaoli Ma; Yihui Xu; Jun Wang; Xiaoqian Zhang; Meihua Gao; Beibei Cong; Shuyi Han
Journal:  Cancer Cell Int       Date:  2019-01-08       Impact factor: 5.722

8.  Fli-1 overexpression in hematopoietic progenitors deregulates T cell development and induces pre-T cell lymphoblastic leukaemia/lymphoma.

Authors:  Monique F M A Smeets; Angela C Chan; Samantha Dagger; Cara K Bradley; Andrew Wei; David J Izon
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

9.  An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma.

Authors:  Yotam Drier; Matthew J Cotton; Kaylyn E Williamson; Shawn M Gillespie; Russell J H Ryan; Michael J Kluk; Christopher D Carey; Scott J Rodig; Lynette M Sholl; Amir H Afrogheh; William C Faquin; Lurdes Queimado; Jun Qi; Michael J Wick; Adel K El-Naggar; James E Bradner; Christopher A Moskaluk; Jon C Aster; Birgit Knoechel; Bradley E Bernstein
Journal:  Nat Genet       Date:  2016-02-01       Impact factor: 38.330

Review 10.  Notch and its oncogenic activity in human malignancies.

Authors:  Marlena Brzozowa-Zasada; Adam Piecuch; Marek Michalski; Oliwia Segiet; Józef Kurek; Marzena Harabin-Słowińska; Romuald Wojnicz
Journal:  Eur Surg       Date:  2017-09-18       Impact factor: 0.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.